Kodiak Sciences Inc (FRA:K27)
€ 3.546 0.072 (2.07%) Market Cap: 211.94 Mil Enterprise Value: 80.00 Mil PE Ratio: 0 PB Ratio: 0.96 GF Score: 37/100

Q4 2023 Kodiak Sciences Inc Earnings Call Transcript

Mar 28, 2024 / 08:30PM GMT
Release Date Price: €5.46 (-19.84%)
Operator

Good day, and thank you for standing by. Welcome to the Kodiak Sciences business update webcast and conference call. (Operator Instructions) Please be advised that today's conference is being recorded.

I would now like to hand the conference over to your first speaker today, John Borgeson, Chief Financial Officer. Please go ahead.

John Borgeson
Kodiak Sciences Inc - Senior Vice President and Chief Financial Officer

Thank you for joining our conference call and webcast to discuss recent business updates at Kodiak. I am John Borgeson, Kodiak's Chief Financial Officer. Joining me today are Victor Perlroth, Chairman and CEO; and Pablo Velazquez-Martin, Senior Vice President of Clinical Research and Development.

After our prepared remarks, we will open the call for Q&A. The webcast portion of this call contains a slide presentation that we will refer to during the call. Those following along on the phone who wish to access the slide portion of this presentation may do so on the Investors and Media section of our website, and an archive of

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot